Pharsight

Drugs that contain Benoxinate Hydrochloride; Fluorescein Sodium

1. Fluorescein Sodium And Benoxinate Hydrochloride patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10842872 BAUSCH LOMB IRELAND Fluorescein and benoxinate compositions
Nov, 2037

(13 years from now)

US10632197 BAUSCH LOMB IRELAND Fluorescein and benoxinate compositions
Nov, 2037

(13 years from now)

US10293047 BAUSCH LOMB IRELAND Fluorescein and benoxinate compositions
Nov, 2037

(13 years from now)

Market Authorisation Date: 09 March, 2020

Treatment: Procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic.; Ocular examination, intraocular pressure measurement, or removal of foreig...

Dosage: SOLUTION/DROPS;OPHTHALMIC

More Information on Dosage

FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE family patents

Family Patents